Gervasoni N - Search Results

1

Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effects.

Choong E, Polari A, Kamdem RH, Gervasoni N, Spisla C, Jaquenoud Sirot E, Bickel GG, Bondolfi G, Conus P, Eap CB. Choong E, et al. Among authors: gervasoni n. J Clin Psychopharmacol. 2013 Jun;33(3):289-98. doi: 10.1097/JCP.0b013e31828f62cd. J Clin Psychopharmacol. 2013. PMID: 23609392

2

Time course of response to paroxetine: influence of plasma level.

Gex-Fabry M, Gervasoni N, Eap CB, Aubry JM, Bondolfi G, Bertschy G. Gex-Fabry M, et al. Among authors: gervasoni n. Prog Neuropsychopharmacol Biol Psychiatry. 2007 May 9;31(4):892-900. doi: 10.1016/j.pnpbp.2007.02.003. Epub 2007 Feb 15. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17395353 Clinical Trial.

3

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response.

Gex-Fabry M, Eap CB, Oneda B, Gervasoni N, Aubry JM, Bondolfi G, Bertschy G. Gex-Fabry M, et al. Among authors: gervasoni n. Ther Drug Monit. 2008 Aug;30(4):474-82. doi: 10.1097/FTD.0b013e31817d6f5d. Ther Drug Monit. 2008. PMID: 18641553

4

The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.

Aubry JM, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, Bondolfi G. Aubry JM, et al. Among authors: gervasoni n. J Psychiatr Res. 2007 Apr-Jun;41(3-4):290-4. doi: 10.1016/j.jpsychires.2006.07.007. Epub 2006 Sep 7. J Psychiatr Res. 2007. PMID: 16956623

5

Performance of the Mood Disorder Questionnaire (MDQ) according to bipolar subtype and symptom severity.

Gervasoni N, Weber Rouget B, Miguez M, Dubuis V, Bizzini V, Gex-Fabry M, Bondolfi G, Aubry JM. Gervasoni N, et al. Eur Psychiatry. 2009 Jun;24(5):341-4. doi: 10.1016/j.eurpsy.2008.12.008. Epub 2009 Feb 6. Eur Psychiatry. 2009. PMID: 19200693

6

Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.

Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM. Gervasoni N, et al. J Psychiatr Res. 2004 Nov-Dec;38(6):553-7. doi: 10.1016/j.jpsychires.2004.04.008. J Psychiatr Res. 2004. PMID: 15458850 Clinical Trial.

7

Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.

Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G. Karege F, et al. Among authors: gervasoni n. Biol Psychiatry. 2005 May 1;57(9):1068-72. doi: 10.1016/j.biopsych.2005.01.008. Biol Psychiatry. 2005. PMID: 15860348 Clinical Trial.

8

The cortisol awakening response in patients remitted from depression.

Aubry JM, Jermann F, Gex-Fabry M, Bockhorn L, Van der Linden M, Gervasoni N, Bertschy G, Rossier MF, Bondolfi G. Aubry JM, et al. Among authors: gervasoni n. J Psychiatr Res. 2010 Dec;44(16):1199-204. doi: 10.1016/j.jpsychires.2010.04.015. Epub 2010 May 13. J Psychiatr Res. 2010. PMID: 20471032

9

Lithium dose prediction based on 24 hours single dose levels: a prospective evaluation.

Gervasoni N, Zona-Favre MP, Osiek Ch, Roth L, Bondolfi G, Bertschy G. Gervasoni N, et al. Pharmacol Res. 2003 Dec;48(6):649-53. doi: 10.1016/s1043-6618(03)00220-2. Pharmacol Res. 2003. PMID: 14527832 Clinical Trial.

10

Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode.

Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, Karege F. Gervasoni N, et al. Neuropsychobiology. 2005;51(4):234-8. doi: 10.1159/000085725. Epub 2005 May 12. Neuropsychobiology. 2005. PMID: 15897674 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page